Trikatu for Metabolism Support

Research suggests that Trikatu and its constituent compounds — particularly piperine from black and long pepper — may support metabolic function primarily through enhancing the bioavailability of co-administered substances by inhibiting certain drug-metabolizing enzymes in the liver and gut, a finding noted consistently across multiple reviews spanning decades of research. Studies indicate that piperine and the Trikatu formulation more broadly may also offer antioxidant, anti-inflammatory, and lipid-modulating effects, with one 2022 narrative review of 13 studies noting potential reductions in inflammatory markers such as TNF-α and IL-6, and another review highlighting possible support for digestion through stimulation of pancreatic enzymes. The available evidence comes predominantly from narrative reviews, preclinical cell and animal studies, and pharmacokinetic investigations, with one mixed-direction study from 2004 directly examining how Trikatu modulates drug metabolism — meaning the evidence base, while directionally consistent, lacks the large-scale randomized controlled trials and meta-analyses needed to draw firm clinical conclusions. Researchers across multiple reviews emphasize that while findings are encouraging, well-designed human trials are still required before confident claims about Trikatu's role in metabolic support can be made.